|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Tumor Biology |
Departments of Neurosurgery [H.H., T.A.] and Pathology [M.G.], Kagoshima University, Kagoshima, Japan 890-8520; and Department of Pathology, Division of Neuropathology [M.B.S.L., J.E.C., L.R.K., S.R.V.], and Department of Neurological Surgery [E.R.L., Jr.], University of Virginia Health Sciences Center, Charlottesville, VA 22908
1 Address correspondence and reprint requests to Scott R. VandenBerg, M.D., Ph.D., Department of Pathology, Neuropathology, University of Virginia Health Science Center, Box 214, Charlottesville, VA 22908.
Abstract
Studies of experimental tumorigenesis have strongly implicated signaling of the insulin-like growth factor 1 (IGF-1) as a key component in astrocytic neoplasia; however, its role in the growth of low-grade and malignant human tumors is not well understood. Correlative analyses of IGF-1, p53, and Ki-67 (MIB-1) immunohistochemistry and IGF-1 receptor (IGF-1R) mRNA expression were performed to examine the cellular pattern of IGF-1 signaling in 39 cases of astrocytoma (World Health Organization grades II–IV). Tumor cells expressing IGF-1 and IGF-1R were present in all tumor grades. The proportion of tumor cells that expressed IGF-1 correlated with both histopathologic grade and Ki-67 labeling indices, while expression of IGF-1R mRNA correlated with Ki-67 indices. In cases where stereotactic tissue sampling could be identified with a specific tumor area by neuroimaging features, the numbers of IGF-1 immunoreactive cells correlated with the tumor zones of highest cellularity and Ki-67 labeling. In glioblastomas, the localization of IGF-1 immunoreactivity was notable for several features: frequent accentuation in the perivascular tumor cells surrounding microvascular hyperplasia; increased levels in reactive astrocytes at the margins of tumor infiltration; and selective expression in microvascular cells exhibiting endothelial/pericytic hyperplasia. IGF-1R expression was particularly prominent in tumor cells adjacent to both microvascular hyperplasia and palisading necrosis. These data suggest that IGF-1 signaling occurs early in astroglial tumorigenesis in the setting of cell proliferation. The distinctive correlative patterns of IGF-1 and IGF-1R expression in glioblastomas also suggest that IGF-1 signaling has an association with the development of malignant phenotypes related to aberrant angiogenesis and invasive tumor interactions with reactive brain.
References
Adams, M.D., Kelley, J.M., Gocayne, J.D., Dubnick, M.,
Polymeropoulos, M.H., Xiao, H., Merril, C.R., Wu, A., Olde, B., Moreno, R.F.,
Kerlavage, A.R., McCombie, W.R., and Venter, J.C. (1991)
Complementary DNA sequencing: Expressed sequence tags and human genome
project. Science 252,1651
-1666.
Ambrose, D., Resnicoff, M., Coppola, D., Sell, C., Miura, M., Jameson, S., Baserga, R., and Rubin, R. (1994) Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor. J. Cell. Physiol. 159,92 -100.[CrossRef][ISI][Medline]
Bar, R.S., Boes, M., Dake, B.L., Booth. B.A., Henley, S.A., and Sandra, A. (1988) Insulin, insulin-like growth factors, and vascular endothelium. Am. J. Med. 85, 59-70.[ISI][Medline]
Bello, L. (1996) Urinary epidermal growth factor (EGF) levels and epidermal growth factor receptor (EGF-R) expression in human cerebral tumors. Clinical considerations. J. Neurosurg. Sci. 40,167 -182.[Medline]
Blum, W.F., Jenne, E.W., Reppin, F., Kietzmann, K., Ranke, M.B., and Bierich, J.R. (1989) Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 125,766 -772.[Abstract]
Bradshaw, S.L., Naus, C.C., Zhu, D., Kidder, G.M., D'Ercole, A.J., and Han, V.K. (1993) Alterations in the synthesis of insulin-like growth factor binding proteins and insulin-like growth factors in rat C6 glioma cells transfected with a gap junction connexin43 cDNA. Regul. Pept. 48,99 -112.[CrossRef][ISI][Medline]
Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B.R., and Kley, N. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377,646 -649.[CrossRef][Medline]
Bui, T., Kuo, C., Rotwein, P., and Straus, D.S. (1997)
Prostaglandin A2 specifically represses insulin-like growth factor-I gene
expression in C6 rat glioma cells. Endocrinology
138,985
-993.
Burgaud, J.L., Resnicoff, M., and Baserga, R. (1995) Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem. Biophys. Res. Commun. 214,475 -481.[CrossRef][ISI][Medline]
Busby, W.H., Jr., Klapper, D.G., and Clemmons, D.R.
(1988) Purification of a 31,000-dalton insulin-like growth factor
binding protein from human amniotic fluid. J. Biol.
Chem. 263,14203
-14210.
Cavenee, W.K., Bigner, D.D., Newcomb, E.W., Paulus, W., and Kleihues, P. (1997) Diffuse astrocytomas. In: Kleihues, P., and Cavenee, W.K. (Eds.), Pathology and Genetics of Tumours of the Nervous System. Lyon: International Agency for Research on Cancer. pp. 2-9.
Chernausek, S.D. (1993) Insulin-like growth factor-1 (IGF-I) production by astroglial cells regulation and importance for epidermal growth factor-induced cell replication. J. Neurosci. Res. 34,189 -197.[CrossRef][ISI][Medline]
Coppola, D., Ferber, A., Miura, M., Sell, C., D'Ambrosio, C.,
Rubin, R., and Baserga, R. (1994) A functional insulin-like
growth factor I receptor is required for the mitogenic and transforming
activities of the epidermal growth factor receptor. Mol. Cell.
Biol. 14,4588
-4595.
De Mellow, J.S.M., and Baxter, R.C. (1988) Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun. 156,199 -204.[CrossRef][ISI][Medline]
Ekstrand, A.J., James, C.D., Cavenee, W.K., Seliger, B.,
Pettersson, R.F., and Collins, V.P. (1991) Genes for epidermal
growth factor receptor, transforming growth factor alpha, and epidermal growth
factor and their expression in human gliomas in vivo. Cancer
Res. 51,2164
-2172.
Ekstrand, A.J., Liu, L., He, J., Hamid, M.L., Longo, N., Collins, V.P., and James, C.D. (1995) Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor. Oncogene 10,1455 -1460.[ISI][Medline]
Elgin, R.G., Busby, W.H., Jr., and Clemmons, D.R.
(1987) An insulin-like growth factor (IGF) binding protein
enhances the biologic response to IGF-I. Proc. Natl. Acad. Sci.
USA 84,3254
-3258.
Faber-Elman, A., Solomon, A., Abraham, J.A., Marikovsky, M., and Schwartz, M. (1996) Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: In vitro simulation. J. Clin. Invest. 97,162 -171.[ISI][Medline]
Fritsche, M., Haessler, C., and Brandner, G. (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8, 307-318.[ISI][Medline]
Gammeltoft, S., Ballotti, R., Nielsen, F.C., Kowalski, A., and Van Obberghen, E. (1988a) Receptors for insulin-like growth factors in the central nervous system: sStructure and function. Horm. Metab. Res. 20,436 -442.[ISI][Medline]
Gammeltoft, S., Ballotti, R., Kowalski, A., Westermark, B., and Van
Obberghen, E. (1988b) Expression of two types of receptor for
insulin-like growth factors in human malignant glioma. Cancer
Res. 48,1233
-1237.
Garcia-Estrada, J., Garcia-Segura, L.M., and Torres-Aleman, I. (1992) Expression of insulin-like growth factor I by astrocytes in response to injury. Brain Res. 592,343 -347.[CrossRef][ISI][Medline]
Glick, R.P., Gettleman, R., Patel, K., Lakshman, R., and Tsibris, J.C. (1989) Insulin and insulin-like growth factor I in brain tumors: Binding and in vitro effects. Neurosurgery 24,791 -797.[ISI][Medline]
Goad, D.L., Rubin, J., Wang, H., Tashjian, A.H., Jr., and Patterson, C. (1996) Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology 137,2262 -2268.[Abstract]
Hollander, M., and Wolfe, D.A. (1973) Nonparametric Statistical Methods. New York: John Wiley & Sons.
Hongo, A., D'Ambrosio, C., Miura, M., Morrione, A., and Baserga, R. (1996) Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 12,1231 -1238.[ISI][Medline]
Hussaini, I.M., Lopes, M.B.S., Musante, D.B., Karns, L.R., and VandenBerg, S.R. (1996) Expression of IGF-1 and IGF-1R in reactive astrocytes and astrocytic tumors. J. Neuropathol. Exp. Neurol. 55,606 . (Abstract)
Jaros, E., Perry, R.H., Adam, L., Kelly, P.J., Crawford, P.J., Kalbag, R.M. Mendelow, A.D., Sengupta, R.P., and Pearson, A.D. (1992) Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br. J. Cancer 66,373 -385.[ISI][Medline]
Jennings, M.T., Maciunas, R.J., Carver, R., Bascom, C.C., Juneau, P., Misulis, K., and Moses, H.L. (1991) TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: Evidence in support of an autocrine hypothesis. Int. J. Cancer 49,129 -139.[ISI][Medline]
Jones, J.I., and Clemmons, D.R. (1995) Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev. 16,3 -34.[CrossRef][ISI][Medline]
Kaleko, M., Rutter, W.J., and Miller, A.D. (1990)
Overexpression of the human insulinlike growth factor I receptor promotes
ligand-dependent neoplastic transformation. Mol. Cell.
Biol. 10,464
-473.
Kim, K.W., Bae, S.K., Lee, O.H., Bac, M.H., Lee, M.J., and Park,
B.C. (1998) Insulin-like growth factor II induced by hypoxia may
contribute to angiogenesis of human hepatocellular carcinoma.
Cancer Res. 58,348
-351.
Kluge, A., Zimmermann, R., Weihrauch, D., Mohri, M., Sack, S.,
Schaper, J., and Schaper, W. (1997) Coordinate expression of the
insulin-like growth factor system after microembolisation in porcine heart.
Cardiovasc. Res. 33,324
-331.
Kulik, G., Klippel, A., and Weber, M.J. (1997) Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17,1595 -1606.[Abstract]
Landau, B.K., Kwaan, H.C., Verrusio, E.N., and Brem, S.S.
(1994) Elevated levels of urokinase-type plasminogen activator
and plasminogen activator inhibitor type-1 in malignant human brain tumors.
Cancer Res. 54,1105
-1108.
Li, S., Resnicoff M., and Baserga, R. (1996) Effect of
mutations at serines 1280-1283 on the mitogenic and transforming activities of
the insulin-like growth factor I receptor. J. Biol.
Chem. 271,12254
-12260.
Louis, D.N. (1997) A molecular genetic model of astrocytoma histopathology. Brain Pathol. 7, 755-764.[ISI][Medline]
McCusker, R.H., Camacho-Hubner, C., Bayne, M.L., Cascieri, M.A., and Clemmons, D.R. (1990) Insulin-like growth factor (IGF) binding to humanfibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs). J. Cell. Physiol. 144,244 -253.[CrossRef][ISI][Medline]
Merrill, M.J., and Edwards, N.A. (1990) Insulin-like growth factor-I receptors in human glial tumors. J. Clin. Endocrinol. Metab. 71,199 -209.[Abstract]
Mohan, S., Bautista, C.M., Wergedal, J., and Baylink, D.J.
(1989) Isolation of an inhibitory insulin-like growth factor
(IGF) binding protein from bone cell-conditioned medium a potential local
regulator of IGF action. Proc. Natl. Acad. Sci. USA
86,8338
-8342.
Nakao-Hayashi, J., Ito, H., Kanayasu, T., Morita, I., and Murota, S. (1992) Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells. Atherosclerosis 92,141 -149.[CrossRef][ISI][Medline]
Punglia, R.S., Lu, M., Hsu, J., Kuroki, M., Tolentino, M.J., Leough, K., Levy, A.P., Levy, N.S., Goldberg, M.A., D'Amato, R.J., and Adamis, A.P. (1997) Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes 46,1619 -1626.[Abstract]
Rao, G.N., Delafontaine, P., and Runge, M.S. (1995)
Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor,
insulin receptor substrate-1, and phospholipase C-gamma 1 in rat aortic smooth
muscle cells. J. Biol. Chem.
270,27871
-27875.
Resnicoff, M., Burgaud, J.L., Rotman, H.L., Abraham, D., and
Baserga, R. (1995) Correlation between apoptosis, tumorigenesis,
and levels of insulin-like growth factor I receptors. Cancer
Res. 55,3739
-3741.
Resnicoff, M., Li, W., Basak, S., Herlyn, D., Baserga, R., and Rubin, R. (1996) Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA. Cancer Immunol. Immunother. 42, 64-68.[CrossRef][ISI][Medline]
Roberts, C.T., Jr. (1996) Control of insulin-like growth factor (IGF) action by regulation of IGF-I receptor expression. Endocrine J. 43 (Suppl.), S49-55.
Ross, M., Francis, G.L., Szabo, L., Wallace, J.C., and Ballard, F.J. (1989) Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-2 but not des-(1-3)-IGF-1. Biochem. J. 258,267 -272.[ISI][Medline]
Rubin, R., and Baserga, R. (1995) Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab. Invest. 73,311 -331.[ISI][Medline]
Rubio, M.P., von Deimling, A., Yandell, D.W., Wiestler, O.D.,
Gusella, J.F., and Louis, D.N. (1993) Accumulation of wild-type
p53 protein in human astrocytomas. Cancer Res.
53,3465
-3467.
Sandberg, A.C., Engberg, C., Lake, M., von Holst, H., and Sara, V.R. (1988) The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma. Neurosci. Lett. 93,114 -119.[CrossRef][ISI][Medline]
Sanfilippo, J.S., Rao, C.V., Guarnaschelli, J.J., Woost, P.G., Byrd, V.M., Jones, E., and Schultz, G.S. (1993) Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings. Surg. Gynecol. Obstet. 177,488 -496.[ISI][Medline]
Sasaoka, T., Rose, D.W., Jhun, B.H., Saltiel, A.R., Draznin, B.,
and Olefsky, J.M. (1994) Evidence for a functional role of Shc
proteins in mitogenic signaling induced by insulin, insulin-like growth
factor-1 and epidermal growth factor. J. Biol. Chem.
269,13689
-13694.
Sato, Y., Okamura, K., Morimoto, A., Hamanaka, R., Hamaguchi, K., Shimada, T., Ono, M., Kohno, K., Sakata, T., and Kuwano, M. (1993) Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. Exp. Cell Res. 204,223 -229.[CrossRef][ISI][Medline]
Sell, C., Rubini, M., Rubin, R., Liu, J.P., Efstratiadis, A., and
Baserga, R. (1993) Simian virus 40 large tumor antigen is unable
to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth
factor receptor. Proc. Natl. Acad. Sci. USA
90,11217
-11221.
Shimasaki, S., Uchiyama, F., Shimonaka, M., and Ling, N. (1990) Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human. Mol. Endocrinol. 4,1451 -1458.[CrossRef][ISI][Medline]
Straus, D.S., and Burke, E.J. (1995) Glucose stimulates IGF-I gene expression in C6 glioma cells. Endocrinology 136,365 -368.[Abstract]
Takahashi, J.A., Mori, H., Fukumoto, M., Igarashi, K., Jaye, M.,
Oda, Y., Kikuchi, H., and Hatanaka, M. (1990) Gene expression of
fibroblast growth factors in human gliomas and meningiomas: Demonstration of
cellular source of basic fibroblastic growth factor mRNA and peptide in tumor
tissues. Proc. Natl. Acad. Sci. USA
87,5710
-5714.
Tournier, C., Pomerance, M., Gavaret, J.M., and Pierre, M. (1994) MAP kinase cascade in astrocytes. Glia 10,81 -88.[CrossRef][ISI][Medline]
Van der Ven, L.T., Van Buul-Offers, S.C., Gloudemans, T., Roholl, P.J., Sussenbach, J.S., and Den Otter, W. (1997) Histamine-stimulated expression of insulin-like growth factors in human glioma cells. Br. J. Cancer 75,1091 -1097.[ISI][Medline]
Van Meir, E.G. (1995) Cytokines and tumors of the central nervous system. Glia 15,264 -288.[CrossRef][ISI][Medline]
Wang, Z.H., Ma, J., Zeng, B.J., Catanese, V.M., Samuels, S., Gama Sosa, M.A., and Kolodny, E.H. (1997) Correlation of glioma cell regression with inhibition of insulin-like growth factor 1 and insulin-like growth factor-binding protein-2 expression. Neuroendocrinology 66,203 -211.[ISI][Medline]
Werner, H., Karnieli, E., Rauscher, F.J., and LeRoith, D.
(1996) Wild-type and mutant p53 differentially regulate
transcription of the insulin-like growth factor I receptor gene.
Proc. Natl. Acad. Sci. USA
93,8318
-8323.
Westermark, B., Heldin, C.H., and Nister, M. (1995) Platelet-derived growth factor in human glioma. Glia 15,257 -263.[CrossRef][ISI][Medline]
Yamada, M., Ikeuchi, T., and Hatanaka, H. (1997) The neurotrophic action and signalling of epidermal growth factor. Prog. Neurobiol. 51,19 -37.[CrossRef][ISI][Medline]
Yamamoto, M., Sawaya, R., Mohanam, S., Rao, V.H., Bruner, J.M., Nicolson, G.L., Ohshima, K., and Rao, J.S. (1994) Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression. J. Neurooncol. 22,139 -151.[CrossRef][Medline]
Yang, B.C., Chang, H.M., Wang, Y.S., Chen, R.F., and Lin, S.J. (1996) Transient induction of apoptosis in serum-starved glioma cells by insulin and IGF-1. Biochim. Biophys. Acta 1314,83 -92.[Medline]
Zheng, B., Clarke, J.B., Busby, W.H., Duan, C., and Clemmons, D.R.
(1998) Insulin-like growth factor-binding protein-5 is cleaved by
physiological concentrations of thrombin.
Endocrinology 139,1708
-1714.
Zumkeller, W., Saaf, M., and Rahn, T. (1993) Insulin-like growth factor (IGF)-I, -II and IGF-binding proteins in the cyst fluid of a patient with astrocytoma. Childs Nerv. Sys. 9, 100-103.[CrossRef][ISI][Medline]
This article has been cited by other articles:
|
|
 |
|
  O. J. Becher, K. M. Peterson, S. Khatua, M. R. Santi, and T. J. MacDonald IGFBP2 Is Overexpressed by Pediatric Malignant Astrocytomas and Induces the Repair Enzyme DNA-PK J Child Neurol, October 1, 2008; 23(10): 1205 - 1213. [Abstract] [PDF]
|
|
|
|
 |
|
 A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights Endocr. Rev., February 1, 2007; 28(1): 20 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. D. Dixit, A. T. Weeraratna, H. Yang, D. Bertak, A. Cooper-Jenkins, G. J. Riggins, C. G. Eberhart, and D. D. Taub Ghrelin and the Growth Hormone Secretagogue Receptor Constitute a Novel Autocrine Pathway in Astrocytoma Motility J. Biol. Chem., June 16, 2006; 281(24): 16681 - 16690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Woerner, N. M. Warrington, A. L. Kung, A. Perry, and J. B. Rubin Widespread CXCR4 Activation in Astrocytomas Revealed by Phospho-CXCR4-Specific Antibodies Cancer Res., December 15, 2005; 65(24): 11392 - 11399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain Endocr. Rev., December 1, 2005; 26(7): 916 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhou, J. Zhang, Q. Liu, R. Bell, D. A. Muruve, P. Forsyth, M. Arcellana-Panlilio, S. Robbins, and V.W. Yong The chemokine GRO-{alpha} (CXCL1) confers increased tumorigenicity to glioma cells Carcinogenesis, December 1, 2005; 26(12): 2058 - 2068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lefranc, J. Brotchi, and R. Kiss Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis J. Clin. Oncol., April 1, 2005; 23(10): 2411 - 2422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Glass, M. Synowitz, G. Kronenberg, J.-H. Walzlein, D. S. Markovic, L.-P. Wang, D. Gast, J. Kiwit, G. Kempermann, and H. Kettenmann Glioblastoma-Induced Attraction of Endogenous Neural Precursor Cells Is Associated with Improved Survival J. Neurosci., March 9, 2005; 25(10): 2637 - 2646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mukherjee, L. E. Abate, and T. N. Seyfried Antiangiogenic and Proapoptotic Effects of Dietary Restriction on Experimental Mouse and Human Brain Tumors Clin. Cancer Res., August 15, 2004; 10(16): 5622 - 5629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Chacko and M. L. Adamo Double-Stranded RNA Decreases IGF-I Gene Expression in a Protein Kinase R-Dependent, but Type I Interferon-Independent, Mechanism in C6 Rat Glioma Cells Endocrinology, February 1, 2002; 143(2): 525 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yokoyama, H. Hirano, N. Wakimaru, K. P. Sarker, and J.-i. Kuratsu Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro Neuro-oncol, January 1, 2001; 3(1): 22 - 28. [Abstract] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
